The economic crisis has drastically curtailed investment in many entrepreneurial endeavors, especially in biotechnology. Several companies are reconsidering plans to go forward with initial public offerings (IPOs) and others are laying off employees. Will the lack of funding and the subsequent bottleneck in innovation deepen our healthcare problems? Should Congress consider yet another bailout of yet another industry?
The preceding article is a "sneak peek" from Industrial Processing Equipment, a newsletter from GlobalSpec. To stay up-to-date and informed on industry trends, products, and technologies, subscribe to Industrial Processing Equipment today.
|